{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:57:22Z","timestamp":1781459842274,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2303400"],"award-info":[{"award-number":["2022YFC2303400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32370992"],"award-info":[{"award-number":["32370992"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.imbio.2025.153124","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:05:55Z","timestamp":1759460755000},"page":"153124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Specific human antibodies against SARS-CoV-2 and monkeypox virus generated via a rapid construction and screening system"],"prefix":"10.1016","volume":"230","author":[{"given":"Guanglei","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanle","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.imbio.2025.153124_bb0005","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.AID-0003-2012","article-title":"Humanized mice for studying human immune responses and generating human monoclonal antibodies","volume":"2","author":"Akkina","year":"2014","journal-title":"Microbiol. Spectr."},{"issue":"7","key":"10.1016\/j.imbio.2025.153124_bb0010","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/eji.201747447","article-title":"Tetramer-based identification of naive antigen-specific B cells within a polyclonal repertoire","volume":"48","author":"Brooks","year":"2018","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.imbio.2025.153124_bb0015","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1021\/bi00605a022","article-title":"Primary structures of N-terminal extra peptide segments linked to variable and constant regions of immunoglobulin light chain precursors - implications on organization and controlled expression of immunoglobulin genes","volume":"17","author":"Burstein","year":"1978","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.imbio.2025.153124_bb0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","article-title":"Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients\u2019 B cells","volume":"182","author":"Cao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2025.153124_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2016.11.004","article-title":"The state-of-play and future of antibody therapeutics","volume":"122","author":"Elgundi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.imbio.2025.153124_bb0030","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.4049\/jimmunol.175.10.6829","article-title":"Antibodies and CD8 T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus","volume":"175","author":"Fang","year":"2005","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2025.153124_bb0035","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.virol.2005.09.056","article-title":"Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host","volume":"345","author":"Fang","year":"2006","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.imbio.2025.153124_bb0040","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1182\/blood-2011-03-341917","article-title":"Ex vivo characterization and isolation of rare memory B cells with antigen tetramers","volume":"118","author":"Franz","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.imbio.2025.153124_bb0045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0022-2143(99)90164-6","article-title":"Clinical applications of anti-CD20 antibodies","volume":"134","author":"Gopal","year":"1999","journal-title":"J. Lab. Clin. Med."},{"issue":"3","key":"10.1016\/j.imbio.2025.153124_bb0050","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40259-019-00354-5","article-title":"Immunogenicity of chimeric antigen receptor T-cell therapeutics","volume":"33","author":"Gorovits","year":"2019","journal-title":"Biodrugs"},{"issue":"1","key":"10.1016\/j.imbio.2025.153124_bb0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbrc.2016.05.033","article-title":"A humanized monoclonal antibody targeting secreted anterior gradient 2 effectively inhibits the xenograft tumor growth","volume":"475","author":"Guo","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.imbio.2025.153124_bb0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1359-6446(98)01245-8","article-title":"Therapeutic antibodies make a comeback","volume":"3","author":"Hughes","year":"1998","journal-title":"Drug Discov. Today"},{"issue":"1\u20132","key":"10.1016\/j.imbio.2025.153124_bb0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jviromet.2009.02.014","article-title":"High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies","volume":"158","author":"Liao","year":"2009","journal-title":"J. Virol. Methods"},{"issue":"2","key":"10.1016\/j.imbio.2025.153124_bb0070","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/21645515.2017.1403703","article-title":"Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO. IL-2Rgammac KO. NOD)","volume":"14","author":"Mendoza","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"issue":"1","key":"10.1016\/j.imbio.2025.153124_bb0075","doi-asserted-by":"crossref","first-page":"12134","DOI":"10.1038\/s41598-021-91597-2","article-title":"Novel neutralizing human monoclonal antibodies against tetanus neurotoxin","volume":"11","author":"Minamitani","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imbio.2025.153124_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108233","article-title":"Monoclonal antibody therapeutics for infectious diseases: beyond normal human immunoglobulin","volume":"240","author":"Otsubo","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.imbio.2025.153124_bb0085","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.it.2021.10.008","article-title":"Single B cell technologies for monoclonal antibody discovery","volume":"42","author":"Pedrioli","year":"2021","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.imbio.2025.153124_bb0090","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/02648725.2013.801235","article-title":"Antibody humanization methods - a review and update","volume":"29","author":"Safdari","year":"2013","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"10.1016\/j.imbio.2025.153124_bb0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41541-017-0019-3","article-title":"Antibody therapies for the prevention and treatment of viral infections","volume":"2","author":"Salazar","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.imbio.2025.153124_bb0100","first-page":"69","article-title":"Fatal course after administration of rituximab in a boy with relapsed all: a case report and review of literature","volume":"91","author":"Seifert","year":"2006","journal-title":"Haematologica"},{"issue":"1\u20132","key":"10.1016\/j.imbio.2025.153124_bb0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J. Immunol. Methods"},{"issue":"7365","key":"10.1016\/j.imbio.2025.153124_bb0110","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"Walker","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.imbio.2025.153124_bb0115","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jim.2008.04.008","article-title":"An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies","volume":"336","author":"Yu","year":"2008","journal-title":"J. Immunol. Methods"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S017129852500258X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S017129852500258X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:10:38Z","timestamp":1781457038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S017129852500258X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S017129852500258X"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2025.153124","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specific human antibodies against SARS-CoV-2 and monkeypox virus generated via a rapid construction and screening system","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2025.153124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153124"}}